Moderna Named a Top Employer by Science for Twelfth Consecutive Year ACCESSWIRE
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on MRNA
    Moderna, Inc. to Join the Nasdaq-100 Index(R) Beginning October 9, 2026
    8:56a ET October 2 '26 GlobeNewswire
    Moderna, Inc. to Join the Nasdaq-100 Index(R) Beginning October 9, 2026GlobeNewswireOctober 02, 2026

    NEW YORK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that Moderna, Inc. (Nasdaq: MRNA) will become a component of the Nasdaq-100 Index(R) (NDX(R)) replacing Warner Bros. Discovery, Inc. (Nasdaq: WBD) prior to market open on Friday, October 9, 2026.

    For additional information, including notifications on changes to any Nasdaq Indexes, please go to https://indexes.nasdaq.com/

    About Nasdaq Global Indexes

    Nasdaq Global Indexes is one of the world's leading index providers, offering a comprehensive suite of rules-based benchmarks and indexes. The Nasdaq-100 Index(R) -- which measures the performance of 100 of the largest Nasdaq-listed non-financial companies -- is tracked by more than 200 investment products with over $800 billion in assets under management globally. Nasdaq Global Indexes publishes and maintains more than 10,000 indexes across asset classes and geographies.

    About Nasdaq

    Nasdaq (Nasdaq: NDAQ) is a leading technology platform that powers the world's economies. We architect the infrastructure of the world's most modern markets, power the innovation economy, and build trust in the financial system. We empower economic opportunity by designing and deploying advanced technology, data, and intelligence solutions that enable our clients to capture opportunities, navigate risk, and strengthen resilience. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Xâ??@Nasdaq, or atâ??www.nasdaq.com.

    Nasdaq(R), Nasdaq-100 Index(R) and NDX(R) are registered trademarks of Nasdaq, Inc. The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither Nasdaq, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq's proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    Media ContactMaximilian Leitenberger Maximilian.leitenberger@nasdaq.com

    Issuer & Investor ContactIndex Client Services Indexservices@nasdaq.com

    -NDAQF-

    COMTEX_493654534/2010/2026-10-02T08:56:39

    NEW YORK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that Moderna, Inc. (Nasdaq: MRNA) will become a component of the Nasdaq-100 Index(R) (NDX(R)) replacing Warner Bros. Discovery, Inc. (Nasdaq: WBD) prior to market open on Friday, October 9, 2026.

    For additional information, including notifications on changes to any Nasdaq Indexes, please go to https://indexes.nasdaq.com/

    About Nasdaq Global Indexes

    Nasdaq Global Indexes is one of the world's leading index providers, offering a comprehensive suite of rules-based benchmarks and indexes. The Nasdaq-100 Index(R) -- which measures the performance of 100 of the largest Nasdaq-listed non-financial companies -- is tracked by more than 200 investment products with over $800 billion in assets under management globally. Nasdaq Global Indexes publishes and maintains more than 10,000 indexes across asset classes and geographies.

    About Nasdaq

    Nasdaq (Nasdaq: NDAQ) is a leading technology platform that powers the world's economies. We architect the infrastructure of the world's most modern markets, power the innovation economy, and build trust in the financial system. We empower economic opportunity by designing and deploying advanced technology, data, and intelligence solutions that enable our clients to capture opportunities, navigate risk, and strengthen resilience. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Xâ??@Nasdaq, or atâ??www.nasdaq.com.

    Nasdaq(R), Nasdaq-100 Index(R) and NDX(R) are registered trademarks of Nasdaq, Inc. The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither Nasdaq, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq's proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    Media ContactMaximilian Leitenberger Maximilian.leitenberger@nasdaq.com

    Issuer & Investor ContactIndex Client Services Indexservices@nasdaq.com

    -NDAQF-

    COMTEX_493654534/2010/2026-10-02T08:56:39

    AI-Designed Biologics Are Moving From the Screen to the Bench, and De...
    9:45a ET October 14 '26 GlobeNewswire
    Moderna to Report Third Quarter 2026 Financial Results on Friday, Nov...
    7:00a ET October 13 '26 ACCESSWIRE
    2026 Takes a Promising Turn in the Fight Against Cancer as Five Advan...
    9:59a ET October 7 '26 GlobeNewswire
    Moderna, Inc. to Join the Nasdaq-100 Index(R) Beginning October 9, 20...
    8:56a ET October 2 '26 GlobeNewswire
    Moderna Adds Chief Operating Officer Role as Company Expands into Onc...
    7:00a ET September 30 '26 ACCESSWIRE
    Moderna Announces Late-Breaking Data to be Presented at ESMO Congress...
    10:12a ET September 21 '26 ACCESSWIRE
    A $57 Billion Antiviral Market Is Taking Shape As The World Prepares ...
    9:00a ET September 15 '26 GlobeNewswire
    AI Drug Discovery Market Projected to Reach $13.8 Billion by 2033
    10:01a ET September 14 '26 CNW Group
    Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convert...
    7:00a ET August 28 '26 ACCESSWIRE
    Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vac...
    3:57p ET August 27 '26 ACCESSWIRE

    Market data provided by News provided by